background
present
pcrbase
nucleic
acid
detect
meet
demand
coronaviru
infecti
diseas
diagnosi
immunosorb
assay
elisa
kit
base
recombin
nucleocapsid
protein
rn
spike
protein
rs
use
detect
igm
igg
antibodi
diagnost
feasibl
evalu
result
among
patient
success
diagnos
rnbase
igm
igg
elisa
respect
success
diagnos
rsbase
igm
igg
elisa
respect
posit
rate
rnbase
rsbase
elisa
antibodi
igm
andor
igg
detect
respect
sensit
rsbase
elisa
igm
detect
significantli
higher
rnbase
elisa
observ
increas
posit
rate
igm
igg
increas
number
day
postdiseas
onset
dpo
posit
rate
igm
drop
dpo
posit
rate
rnbase
rsbase
igm
igg
elisa
less
earli
stage
ill
dpo
igm
igg
obvious
increas
dpo
conclus
elisa
high
sensit
especi
detect
serum
sampl
patient
dpo
import
supplementari
method
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ongo
outbreak
coronaviru
infecti
diseas
emerg
wuhan
china
caus
novel
coronaviru
name
sever
acut
respiratori
syndrom
coronaviru
march
laboratoryconfirm
case
report
china
diseas
spread
countri
asia
australia
europ
north
america
identifi
beta
coronaviru
show
close
relat
ident
bat
cov
distinct
sarscov
receptorbind
domain
rbd
structur
similar
sarscov
function
import
orf
major
structur
protein
includ
spick
membran
envelop
e
nucleocapsid
n
protein
also
well
annot
accord
previou
report
e
protein
necessari
viru
assembl
protein
import
attach
host
cell
rbd
protein
mediat
interact
angiotensinconvert
enzym
protein
locat
surfac
viral
particl
report
highli
immunogen
n
protein
one
major
structur
protein
viru
involv
transcript
replic
viral
rna
packag
encapsid
genom
virion
interfer
cell
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
therefor
current
test
difficult
achiev
meaning
assess
proport
symptomat
patient
infect
rapid
accur
detect
method
urgent
need
serolog
assay
accur
effici
method
screen
mani
pathogen
specif
igm
igg
antibodi
detect
elisa
rel
high
throughput
capac
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
less
stringent
specimen
requir
uniformli
serum
collect
rnabas
assay
present
studi
conduct
evalu
perform
rnbase
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
cutoff
valu
test
consid
neg
greater
equal
cutoff
valu
test
consid
posit
igg
detect
elisa
plate
coat
rn
protein
serum
sampl
dilut
dilut
buffer
ad
plate
incub
wash
hrpconjug
monoclon
mous
antihuman
igg
antibodi
ad
plate
detect
oper
step
perform
describ
igm
detect
cutoff
valu
calcul
sum
averag
neg
control
replic
cutoff
valu
test
consid
neg
greater
equal
cutoff
valu
test
consid
posit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
cutoff
valu
test
consid
neg
greater
equal
cutoff
valu
test
consid
posit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
serum
sampl
collect
patient
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
igm
andor
igg
posit
rate
dpo
later
stage
diseas
tabl
rsbase
elisa
similar
trend
igm
igg
posit
rate
observ
fig
posit
rate
igm
littl
higher
igg
differ
diseas
stage
except
dpo
possibl
due
higher
sensit
rsbase
igm
detect
igg
detect
tabl
verifi
specif
elisa
assay
sampl
healthi
blood
sensit
rsbase
igm
elisa
significantli
higher
rnbase
elisa
p
signific
differ
rsand
rnbase
elisa
observ
detect
igg
total
antibodi
igm
igg
fig
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
signific
differ
two
antigenbas
elisa
observ
igm
detect
group
igg
detect
signific
differ
two
kit
group
studi
rnand
rsbase
elisa
detect
igm
igg
patient
evalu
tabl
total
detect
posit
rate
igm
two
kit
significantli
higher
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
amount
data
serolog
diagnosi
use
antibodi
avail
studi
evalu
immunoassay
detect
antibodi
specif
evalu
igm
igg
product
diagnost
valu
rnand
rsbase
elisa
use
detect
igm
igg
serum
sampl
confirm
patient
result
reveal
rsbase
elisa
sensit
rnbase
one
detect
igm
antibodi
fig
specul
differ
due
rel
high
sensit
earli
respons
antigen
compar
n
antigen
patient
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
could
collect
sampl
patient
discharg
combin
rnand
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
author
declar
conflict
interest
exist
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
